These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2439697)

  • 1. Quantitative structure/activity relations based on use-dependent block and repriming kinetics in myocardium.
    Courtney KR
    J Mol Cell Cardiol; 1987 Mar; 19(3):319-30. PubMed ID: 2439697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying antiarrhythmic drug blocking during action potentials in guinea-pig papillary muscle.
    Courtney KR
    J Mol Cell Cardiol; 1983 Nov; 15(11):749-57. PubMed ID: 6317870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure activity studies of antiarrhythmic properties in a series of lidocaine and procainamide derivatives.
    Ehring GR; Moyer JW; Hondeghem LM
    J Pharmacol Exp Ther; 1988 Feb; 244(2):479-92. PubMed ID: 2450194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of Vmax block of INa-mediated action potentials during combined application of antiarrhythmic drugs in cardiac muscle.
    Kohlhardt M; Seifert C
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):235-44. PubMed ID: 2414674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative actions of mexiletine on sodium channels in nerve, skeletal and cardiac muscle.
    Courtney KR
    Eur J Pharmacol; 1981 Aug; 74(1):9-18. PubMed ID: 6274652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a specific receptor site for lidocaine, quinidine, and bupivacaine associated with cardiac sodium channels in guinea pig ventricular myocardium.
    Clarkson CW; Hondeghem LM
    Circ Res; 1985 Apr; 56(4):496-506. PubMed ID: 2579747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Block of sodium currents by antiarrhythmic agents: analysis of the electrophysiologic effects of propafenone in heart muscle.
    Kohlhardt M
    Am J Cardiol; 1984 Nov; 54(9):13D-19D. PubMed ID: 6093494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative inotropic effects of tetrodotoxin and seven class 1 antiarrhythmic drugs in relation to sodium channel blockade.
    Honerjäger P; Loibl E; Steidl I; Schönsteiner G; Ulm K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):184-95. PubMed ID: 2422563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological evidence that local anesthetics and antiarrhythmic drugs bind to a specific receptor site in cardiac sodium channels: displacement of bupivacaine by lidocaine.
    Clarkson CW; Hondeghem LM
    Proc West Pharmacol Soc; 1984; 27():23-5. PubMed ID: 6093130
    [No Abstract]   [Full Text] [Related]  

  • 10. Two types of sodium channel block by class-I antiarrhythmic drugs studied by using Vmax of action potential in single ventricular myocytes.
    Kodama I; Honjo H; Kamiya K; Toyama J
    J Mol Cell Cardiol; 1990 Jan; 22(1):1-12. PubMed ID: 2157851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Block of cardiac sodium channels by antiarrhythmic drugs.
    Kodama I; Toyama J
    Jpn Circ J; 1988 Mar; 52(3):231-7. PubMed ID: 2453687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined application of class I antiarrhythmic drugs causes "additive", "reductive", or "synergistic" sodium channel block in cardiac muscles.
    Kawamura T; Kodama I; Toyama J; Hayashi H; Saito H; Yamada K
    Cardiovasc Res; 1990 Nov; 24(11):925-31. PubMed ID: 2176934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electropharmacology of Ro 22-9194, a new antiarrhythmic agent.
    Kodama I; Maruyama K; Suzuki R; Honjo H; Toyama J
    Gen Pharmacol; 1996 Jul; 27(5):755-60. PubMed ID: 8842676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use dependent depression of fast sodium current in heart muscle by the new antiarrhythmic substance Bonnecor (AWD 19-166, GS 015).
    Nilius B; Benndorf K; Schüttler K; Boldt W
    Pharmazie; 1985 Dec; 40(12):852-4. PubMed ID: 2419929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kinetics of the blocking action of antifibrillatory drugs on sodium channels in myocardial fibers].
    Heistracher P; Thaler E; Liebeswar G
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):351-2. PubMed ID: 4253791
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between excitability block and negative inotropic actions of antiarrhythmic drugs.
    Courtney KR
    Proc West Pharmacol Soc; 1984; 27():181-4. PubMed ID: 6093127
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of a new antiarrhythmic compound [2-benzal-1-(2' diisopropyl-amino-ethoxy-imino)-cycloheptane hydrogen fumarate] on the electrophysiological properties of mammalian cardiac cells.
    Rüdiger HJ; Homburger H; Antoni H
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):238-44. PubMed ID: 6275279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relations for frequency-dependent sodium channel block in nerve by local anesthetics.
    Courtney KR
    J Pharmacol Exp Ther; 1980 Apr; 213(1):114-9. PubMed ID: 6965720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists.
    Cohen CJ; Spires S; Van Skiver D
    J Gen Physiol; 1992 Oct; 100(4):703-28. PubMed ID: 1281221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate, rhythm and voltage dependent effects of phenytoin: a test of a model of the mechanisms of action of antiarrhythmic drugs.
    Ehring GR; Hondeghem LM
    Proc West Pharmacol Soc; 1978; 21():63-5. PubMed ID: 693541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.